414 related articles for article (PubMed ID: 19467281)
1. The membrane action mechanism of analogs of the antimicrobial peptide Buforin 2.
Hao G; Shi YH; Tang YL; Le GW
Peptides; 2009 Aug; 30(8):1421-7. PubMed ID: 19467281
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide.
Koo YS; Kim JM; Park IY; Yu BJ; Jang SA; Kim KS; Park CB; Cho JH; Kim SC
Peptides; 2008 Jul; 29(7):1102-8. PubMed ID: 18406495
[TBL] [Abstract][Full Text] [Related]
3. Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.
Zhang L; Benz R; Hancock RE
Biochemistry; 1999 Jun; 38(25):8102-11. PubMed ID: 10387056
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide interaction is decisive for the activity of the antimicrobial peptide NK-2 against Escherichia coli and Proteus mirabilis.
Hammer MU; Brauser A; Olak C; Brezesinski G; Goldmann T; Gutsmann T; Andrä J
Biochem J; 2010 Apr; 427(3):477-88. PubMed ID: 20187872
[TBL] [Abstract][Full Text] [Related]
5. Membrane translocation mechanism of the antimicrobial peptide buforin 2.
Kobayashi S; Chikushi A; Tougu S; Imura Y; Nishida M; Yano Y; Matsuzaki K
Biochemistry; 2004 Dec; 43(49):15610-6. PubMed ID: 15581374
[TBL] [Abstract][Full Text] [Related]
6. Acidic peptide-mediated expression of the antimicrobial peptide buforin II as tandem repeats in Escherichia coli.
Lee JH; Minn I; Park CB; Kim SC
Protein Expr Purif; 1998 Feb; 12(1):53-60. PubMed ID: 9473457
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb.
Jang SA; Kim H; Lee JY; Shin JR; Kim DJ; Cho JH; Kim SC
Peptides; 2012 Apr; 34(2):283-9. PubMed ID: 22306477
[TBL] [Abstract][Full Text] [Related]
8. Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs.
Lee EK; Kim YC; Nan YH; Shin SY
Peptides; 2011 Jun; 32(6):1123-30. PubMed ID: 21497177
[TBL] [Abstract][Full Text] [Related]
9. Lipid-binding and antimicrobial properties of synthetic peptides of bovine apolipoprotein A-II.
Motizuki M; Itoh T; Satoh T; Yokota S; Yamada M; Shimamura S; Samejima T; Tsurugi K
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):215-21. PubMed ID: 10432319
[TBL] [Abstract][Full Text] [Related]
10. [The action mechanism of analogues of the antimicrobial peptide Buforin II with E. coli genomic DNA].
Hao G; Shi Y; Tang Y; Le G
Wei Sheng Wu Xue Bao; 2010 Mar; 50(3):328-33. PubMed ID: 20499637
[TBL] [Abstract][Full Text] [Related]
11. Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.
Zhu WL; Hahm KS; Shin SY
J Pept Sci; 2009 Sep; 15(9):569-75. PubMed ID: 19455552
[TBL] [Abstract][Full Text] [Related]
12. [Molecular design, structural analysis and bactericidal activity of derivatives of antimicrobial peptide buforin II].
Hao G; Le GW; Shi YH; Ma DY
Yao Xue Xue Bao; 2013 Mar; 48(3):366-71. PubMed ID: 23724649
[TBL] [Abstract][Full Text] [Related]
13. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity and mechanism of action of chlorogenic acid.
Lou Z; Wang H; Zhu S; Ma C; Wang Z
J Food Sci; 2011 Aug; 76(6):M398-403. PubMed ID: 22417510
[TBL] [Abstract][Full Text] [Related]
15. Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization.
Domadia PN; Bhunia A; Ramamoorthy A; Bhattacharjya S
J Am Chem Soc; 2010 Dec; 132(51):18417-28. PubMed ID: 21128620
[TBL] [Abstract][Full Text] [Related]
16. Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli.
Mangoni ML; Papo N; Barra D; Simmaco M; Bozzi A; Di Giulio A; Rinaldi AC
Biochem J; 2004 Jun; 380(Pt 3):859-65. PubMed ID: 15032749
[TBL] [Abstract][Full Text] [Related]
17. A novel antimicrobial peptide from Bufo bufo gargarizans.
Park CB; Kim MS; Kim SC
Biochem Biophys Res Commun; 1996 Jan; 218(1):408-13. PubMed ID: 8573171
[TBL] [Abstract][Full Text] [Related]
18. Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.
Yamamoto N; Tamura A
Peptides; 2010 May; 31(5):794-805. PubMed ID: 20109510
[TBL] [Abstract][Full Text] [Related]
19. Effect of proline position on the antimicrobial mechanism of buforin II.
Xie Y; Fleming E; Chen JL; Elmore DE
Peptides; 2011 Apr; 32(4):677-82. PubMed ID: 21277926
[TBL] [Abstract][Full Text] [Related]
20. Investigating the nucleic acid interactions and antimicrobial mechanism of buforin II.
Uyterhoeven ET; Butler CH; Ko D; Elmore DE
FEBS Lett; 2008 May; 582(12):1715-8. PubMed ID: 18448075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
